Compile Data Set for Download or QSAR

Found 147 hits of ic50 for UniProtKB: P35222   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Catenin beta-1 (Homo sapiens (Human))	BDBM50408050 (CHEMBL5282944) Show SMILES [#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-1-[#6]-[#6@H](-[#8])-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-c1cccs1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#8])-[#6](=O)-[#7]-[#6@H](-[#6]-c1ccccc1)-[#6](=O)-[#7](-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](-[#8])=O)-c1ccccc1 Show InChI InChI=1S/C57H83N19O13S/c58-37(17-7-21-65-55(59)60)47(81)71-38(18-8-22-66-56(61)62)51(85)74-24-10-20-43(74)53(87)76-30-35(78)27-44(76)50(84)68-29-45(79)70-40(28-36-16-11-25-90-36)48(82)73-42(32-77)49(83)72-41(26-33-12-3-1-4-13-33)52(86)75(34-14-5-2-6-15-34)31-46(80)69-39(54(88)89)19-9-23-67-57(63)64/h1-6,11-16,25,35,37-44,77-78H,7-10,17-24,26-32,58H2,(H,68,84)(H,69,80)(H,70,79)(H,71,81)(H,72,83)(H,73,82)(H,88,89)(H4,59,60,65)(H4,61,62,66)(H4,63,64,67)/t35-,37+,38+,39+,40+,41-,42+,43+,44+/m1/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL KEGG PC cid PC sid UniChem Similars		n/a	n/a	4.20	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Affinity for CCK2 receptor assessed by inhibition of pentagastrin-stimulated acid secretion in perfused rat stomach				Citation and Details
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396286 (US10314832, Compound 2) Show SMILES O=C(CCC(=O)c1ccccn1)c1ccc2OCCOc2c1 Show InChI InChI=1S/C17H15NO4/c19-14(5-6-15(20)13-3-1-2-8-18-13)12-4-7-16-17(11-12)22-10-9-21-16/h1-4,7-8,11H,5-6,9-10H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	n/a	n/a	13	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396284 (US10314832, Compound 1) Show SMILES O=C(CCC(=O)c1ccc2OCCOc2c1)c1ccccc1 Show InChI InChI=1S/C18H16O4/c19-15(13-4-2-1-3-5-13)7-8-16(20)14-6-9-17-18(12-14)22-11-10-21-17/h1-6,9,12H,7-8,10-11H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	n/a	n/a	28.5	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396287 (US10314832, Compound 3) Show SMILES O=C(CCC(=O)c1ccc2OCCOc2c1)c1cccs1 Show InChI InChI=1S/C16H14O4S/c17-12(4-5-13(18)16-2-1-9-21-16)11-3-6-14-15(10-11)20-8-7-19-14/h1-3,6,9-10H,4-5,7-8H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	38.5	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396292 (US10314832, Compound 8) Show SMILES Oc1ccccc1C(=O)CCC(=O)c1ccc2OCCOc2c1 Show InChI InChI=1S/C18H16O5/c19-14(6-7-16(21)13-3-1-2-4-15(13)20)12-5-8-17-18(11-12)23-10-9-22-17/h1-5,8,11,20H,6-7,9-10H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	83	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396291 (US10314832, Compound 7) Show SMILES Fc1ccc(cc1)C(=O)CCC(=O)c1ccc2OCCOc2c1 Show InChI InChI=1S/C18H15FO4/c19-14-4-1-12(2-5-14)15(20)6-7-16(21)13-3-8-17-18(11-13)23-10-9-22-17/h1-5,8,11H,6-7,9-10H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	183	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148380 (US9682961, 29) Show SMILES OCc1cc(Nc2ncc3cccc(O[C@@H]4CC[C@H](O)CC4)c3n2)cc2[nH]cnc12 |r,wU:15.14,18.18,(-3.48,5,;-4.82,4.23,;-4.82,2.69,;-3.48,1.93,;-3.48,.38,;-2.15,-.38,;-.82,.38,;-.82,1.93,;.52,2.69,;1.85,1.93,;3.19,2.69,;4.52,1.93,;4.52,.38,;3.19,-.38,;3.19,-1.93,;4.52,-2.69,;4.52,-4.23,;5.85,-5,;7.19,-4.23,;8.52,-5,;7.19,-2.69,;5.85,-1.92,;1.85,.38,;.52,-.38,;-4.82,-.38,;-6.15,.38,;-7.61,-.09,;-8.52,1.15,;-7.61,2.4,;-6.15,1.93,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM143712 (US9682961, 1) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccc4nc[nH]c4c3)nc12 |r,wU:4.7,1.0,(8.52,-4.99,;7.19,-4.22,;5.85,-4.99,;4.52,-4.22,;4.52,-2.68,;5.85,-1.91,;7.19,-2.68,;3.19,-1.91,;3.19,-.37,;4.52,.4,;4.52,1.94,;3.19,2.71,;1.85,1.94,;.52,2.71,;-.82,1.94,;-.82,.4,;-2.15,-.37,;-3.48,.4,;-3.48,1.94,;-4.82,2.71,;-6.15,1.94,;-7.61,2.41,;-8.52,1.17,;-7.61,-.08,;-6.15,.4,;-4.82,-.37,;.52,-.37,;1.85,.4,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148359 (US9682961, 13) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccc4[nH]c(CN5CCCC5)nc4c3)nc12 |r,wU:4.7,1.0,(10.68,-3.85,;9.35,-3.08,;8.02,-3.85,;6.68,-3.08,;6.68,-1.54,;8.02,-.77,;9.35,-1.54,;5.35,-.77,;5.35,.77,;6.68,1.54,;6.68,3.08,;5.35,3.85,;4.01,3.08,;2.68,3.85,;1.35,3.08,;1.35,1.54,;.01,.77,;-1.32,1.54,;-1.32,3.08,;-2.65,3.85,;-3.99,3.08,;-5.45,3.56,;-6.36,2.31,;-7.9,2.31,;-8.67,.98,;-10.21,.98,;-10.68,-.49,;-9.44,-1.39,;-8.19,-.49,;-5.45,1.06,;-3.99,1.54,;-2.65,.77,;2.68,.77,;4.01,1.54,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Transcription factor 7-like 2 (Homo sapiens (Human))	BDBM40314 (3-(4-Chloro-phenyl)-1,6-dimethyl-1H-pyrimido[5,4-e...) Show SMILES Cn1nc(nc2c1nc(=O)n(C)c2=O)-c1ccc(Cl)cc1 Show InChI InChI=1S/C13H10ClN5O2/c1-18-12(20)9-11(16-13(18)21)19(2)17-10(15-9)7-3-5-8(14)6-4-7/h3-6H,1-2H3	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	Purchase PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	300	n/a	n/a	n/a	n/a	n/a	n/a
University of Michigan Curated by ChEMBL					Assay Description Inhibition of human TCF4/ flag epitope-tagged beta-catenin (unknown origin) interaction transfected in human HCT116 cells after 24 hrs by beta-galact...				Bioorg Med Chem Lett 23: 5814-20 (2013) Article DOI: 10.1016/j.bmcl.2013.08.111 BindingDB Entry DOI: 10.7270/Q2RV0Q4J
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148402 (US9682961, 44) Show SMILES OCc1n[nH]c2cc(Nc3ncc4ccc(F)c(O[C@@H]5CC[C@H](O)CC5)c4n3)ccc12 |r,wU:19.18,22.22,(-6.92,4.99,;-8.01,3.9,;-7.61,2.41,;-8.52,1.17,;-7.61,-.08,;-6.15,.4,;-4.82,-.37,;-3.48,.4,;-2.15,-.37,;-.82,.4,;-.82,1.94,;.52,2.71,;1.85,1.94,;3.19,2.71,;4.52,1.94,;4.52,.4,;5.85,-.37,;3.19,-.37,;3.19,-1.91,;4.52,-2.68,;4.52,-4.22,;5.85,-4.99,;7.19,-4.22,;8.52,-4.99,;7.19,-2.68,;5.85,-1.91,;1.85,.4,;.52,-.37,;-3.48,1.94,;-4.82,2.71,;-6.15,1.94,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148401 (US9682961, 43) Show SMILES O[C@H]1CC[C@H](CC1)Oc1c(F)ccc2cnc(Nc3ccc4ncccc4c3)nc12 |r,wU:4.7,1.0,(8.67,-3.85,;7.34,-3.08,;6,-3.85,;4.67,-3.08,;4.67,-1.54,;6,-.77,;7.34,-1.54,;3.33,-.77,;3.33,.77,;4.67,1.54,;6,.77,;4.67,3.08,;3.33,3.85,;2,3.08,;.67,3.85,;-.67,3.08,;-.67,1.54,;-2,.77,;-3.33,1.54,;-3.33,3.08,;-4.67,3.85,;-6,3.08,;-7.34,3.85,;-8.67,3.08,;-8.67,1.54,;-7.34,.77,;-6,1.54,;-4.67,.77,;.67,.77,;2,1.54,)| Show InChI InChI=1S/C23H21FN4O2/c24-19-9-3-15-13-26-23(27-16-4-10-20-14(12-16)2-1-11-25-20)28-21(15)22(19)30-18-7-5-17(29)6-8-18/h1-4,9-13,17-18,29H,5-8H2,(H,26,27,28)/t17-,18+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148400 (US9682961, 42) Show SMILES O[C@H]1CC[C@H](CC1)Oc1c(F)ccc2cnc(Nc3ccc4ncsc4c3)nc12 |r,wU:4.7,1.0,(8.52,-3.85,;7.19,-3.08,;5.85,-3.85,;4.52,-3.08,;4.52,-1.54,;5.85,-.77,;7.19,-1.54,;3.19,-.77,;3.19,.77,;4.52,1.54,;5.85,.77,;4.52,3.08,;3.19,3.85,;1.85,3.08,;.52,3.85,;-.82,3.08,;-.82,1.54,;-2.15,.77,;-3.48,1.54,;-3.48,3.08,;-4.82,3.85,;-6.15,3.08,;-7.61,3.56,;-8.52,2.31,;-7.61,1.06,;-6.15,1.54,;-4.82,.77,;.52,.77,;1.85,1.54,)| Show InChI InChI=1S/C21H19FN4O2S/c22-16-7-1-12-10-23-21(25-13-2-8-17-18(9-13)29-11-24-17)26-19(12)20(16)28-15-5-3-14(27)4-6-15/h1-2,7-11,14-15,27H,3-6H2,(H,23,25,26)/t14-,15+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148391 (US9682961, 37) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccnc4ccccc34)nc12 |r,wU:4.7,1.0,(8,-3.85,;6.67,-3.08,;5.33,-3.85,;4,-3.08,;4,-1.54,;5.33,-.77,;6.67,-1.54,;2.67,-.77,;2.67,.77,;4,1.54,;4,3.08,;2.67,3.85,;1.33,3.08,;,3.85,;-1.33,3.08,;-1.33,1.54,;-2.67,.77,;-4,1.54,;-4,3.08,;-5.33,3.85,;-6.67,3.08,;-6.67,1.54,;-8,.77,;-8,-.77,;-6.67,-1.54,;-5.33,-.77,;-5.33,.77,;,.77,;1.33,1.54,)| Show InChI InChI=1S/C23H22N4O2/c28-16-8-10-17(11-9-16)29-21-7-3-4-15-14-25-23(27-22(15)21)26-20-12-13-24-19-6-2-1-5-18(19)20/h1-7,12-14,16-17,28H,8-11H2,(H,24,25,26,27)/t16-,17+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148390 (US9682961, 36) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccc4scnc4c3)nc12 |r,wU:4.7,1.0,(8.52,-3.85,;7.19,-3.08,;5.85,-3.85,;4.52,-3.08,;4.52,-1.54,;5.85,-.77,;7.19,-1.54,;3.19,-.77,;3.19,.77,;4.52,1.54,;4.52,3.08,;3.19,3.85,;1.85,3.08,;.52,3.85,;-.82,3.08,;-.82,1.54,;-2.15,.77,;-3.48,1.54,;-3.48,3.08,;-4.82,3.85,;-6.15,3.08,;-7.61,3.56,;-8.52,2.31,;-7.61,1.06,;-6.15,1.54,;-4.82,.77,;.52,.77,;1.85,1.54,)| Show InChI InChI=1S/C21H20N4O2S/c26-15-5-7-16(8-6-15)27-18-3-1-2-13-11-22-21(25-20(13)18)24-14-4-9-19-17(10-14)23-12-28-19/h1-4,9-12,15-16,26H,5-8H2,(H,22,24,25)/t15-,16+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148385 (US9682961, 31) Show SMILES O[C@H]1CC[C@H](CC1)Oc1c(Br)ccc2cnc(Nc3ccc4nc[nH]c4c3)nc12 |r,wU:4.7,1.0,(8.52,-3.85,;7.19,-3.08,;5.85,-3.85,;4.52,-3.08,;4.52,-1.54,;5.85,-.77,;7.19,-1.54,;3.19,-.77,;3.19,.77,;4.52,1.54,;5.85,.77,;4.52,3.08,;3.19,3.85,;1.85,3.08,;.52,3.85,;-.82,3.08,;-.82,1.54,;-2.15,.77,;-3.48,1.54,;-3.48,3.08,;-4.82,3.85,;-6.15,3.08,;-7.61,3.56,;-8.52,2.31,;-7.61,1.06,;-6.15,1.54,;-4.82,.77,;.52,.77,;1.85,1.54,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<300	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50014132 (CHEMBL2323032) Show SMILES On1ncc2cc(CCc3nn[nH]n3)ccc12 Show InChI InChI=1S/C10H10N6O/c17-16-9-3-1-7(5-8(9)6-11-16)2-4-10-12-14-15-13-10/h1,3,5-6,17H,2,4H2,(H,12,13,14,15)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Similars		n/a	n/a	500	n/a	n/a	n/a	n/a	n/a	n/a
TBA					Assay Description Affinity for CCK2 receptor assessed by inhibition of pentagastrin-stimulated acid secretion in perfused rat stomach				Citation and Details
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148399 (US9682961, 41) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3cccc4cnccc34)nc12 |r,wU:4.7,1.0,(8,-3.85,;6.67,-3.08,;5.33,-3.85,;4,-3.08,;4,-1.54,;5.33,-.77,;6.67,-1.54,;2.67,-.77,;2.67,.77,;4,1.54,;4,3.08,;2.67,3.85,;1.33,3.08,;,3.85,;-1.33,3.08,;-1.33,1.54,;-2.67,.77,;-4,1.54,;-4,3.08,;-5.33,3.85,;-6.67,3.08,;-6.67,1.54,;-8,.77,;-8,-.77,;-6.67,-1.54,;-5.33,-.77,;-5.33,.77,;,.77,;1.33,1.54,)| Show InChI InChI=1S/C23H22N4O2/c28-17-7-9-18(10-8-17)29-21-6-2-4-16-14-25-23(27-22(16)21)26-20-5-1-3-15-13-24-12-11-19(15)20/h1-6,11-14,17-18,28H,7-10H2,(H,25,26,27)/t17-,18+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148360 (US9682961, 14) Show SMILES OCc1nc2cc(Nc3ncc4cccc(O[C@@H]5CC[C@H](O)CC5)c4n3)ccc2[nH]1 |r,wU:17.16,20.20,(-9.68,.98,;-8.91,2.31,;-7.37,2.31,;-6.46,1.06,;-5,1.54,;-3.66,.77,;-2.33,1.54,;-.99,.77,;.34,1.54,;.34,3.08,;1.67,3.85,;3.01,3.08,;4.34,3.85,;5.67,3.08,;5.67,1.54,;4.34,.77,;4.34,-.77,;5.67,-1.54,;5.67,-3.08,;7.01,-3.85,;8.34,-3.08,;9.68,-3.85,;8.34,-1.54,;7.01,-.77,;3.01,1.54,;1.67,.77,;-2.33,3.08,;-3.66,3.85,;-5,3.08,;-6.46,3.56,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148364 (US9682961, 17) Show SMILES Cc1ccc2cnc(Nc3ccc4nc[nH]c4c3)nc2c1O[C@@H]1CC[C@H](O)CC1 |r,wU:22.25,25.29,(5.85,.77,;4.52,1.54,;4.52,3.08,;3.19,3.85,;1.85,3.08,;.52,3.85,;-.82,3.08,;-.82,1.54,;-2.15,.77,;-3.48,1.54,;-3.48,3.08,;-4.82,3.85,;-6.15,3.08,;-7.61,3.56,;-8.52,2.31,;-7.61,1.06,;-6.15,1.54,;-4.82,.77,;.52,.77,;1.85,1.54,;3.19,.77,;3.19,-.77,;4.52,-1.54,;4.52,-3.08,;5.85,-3.85,;7.19,-3.08,;8.52,-3.85,;7.19,-1.54,;5.85,-.77,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148384 (US9682961, 30) Show SMILES Cc1cc2nc[nH]c2cc1Nc1ncc2cccc(O[C@@H]3CC[C@H](O)CC3)c2n1 |r,wU:20.21,23.25,(-2.93,4,;-3.96,2.85,;-5.47,3.18,;-6.5,2.03,;-8.04,2.03,;-8.52,.57,;-7.27,-.34,;-6.02,.57,;-4.52,.25,;-3.49,1.39,;-2.15,.62,;-.82,1.39,;-.82,2.93,;.51,3.7,;1.85,2.93,;3.18,3.7,;4.51,2.93,;4.51,1.39,;3.18,.62,;3.18,-.92,;4.51,-1.69,;4.51,-3.23,;5.85,-4,;7.18,-3.23,;8.52,-4,;7.18,-1.69,;5.85,-.92,;1.85,1.39,;.51,.62,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148365 (US9682961, 18) Show SMILES Cc1nc2ccc(Nc3ncc4ccc(Br)c(O[C@@H]5CC[C@H](O)CC5)c4n3)cc2[nH]1 |r,wU:18.17,21.21,(-9.29,2.31,;-7.75,2.31,;-6.84,3.56,;-5.38,3.08,;-4.05,3.85,;-2.71,3.08,;-2.71,1.54,;-1.38,.77,;-.05,1.54,;-.05,3.08,;1.29,3.85,;2.62,3.08,;3.96,3.85,;5.29,3.08,;5.29,1.54,;6.62,.77,;3.96,.77,;3.96,-.77,;5.29,-1.54,;5.29,-3.08,;6.62,-3.85,;7.96,-3.08,;9.29,-3.85,;7.96,-1.54,;6.62,-.77,;2.62,1.54,;1.29,.77,;-4.05,.77,;-5.38,1.54,;-6.84,1.06,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148378 (US9682961, 27) Show SMILES C[C@H](O)c1nc2ccc(Nc3ncc4cccc(O[C@@H]5CC[C@H](O)CC5)c4n3)cc2[nH]1 |r,wU:1.1,wD:19.18,22.22,(-6.62,-4.32,;-5.08,-4.32,;-4.31,-5.65,;-4.31,-2.99,;-2.78,-2.83,;-2.46,-1.32,;-1.12,-.55,;-1.12,.99,;-2.46,1.76,;-2.46,3.3,;-1.12,4.07,;-1.12,5.61,;.21,6.38,;1.55,5.61,;2.88,6.38,;4.21,5.61,;4.21,4.07,;2.88,3.3,;2.88,1.76,;4.21,.99,;5.55,1.76,;6.88,.99,;6.88,-.55,;8.21,-1.32,;5.55,-1.32,;4.21,-.55,;1.55,4.07,;.21,3.3,;-3.79,.99,;-3.79,-.55,;-4.93,-1.58,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148396 (US9682961, 39) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccc4cnccc4c3)nc12 |r,wU:4.7,1.0,(8.67,-3.85,;7.34,-3.08,;6,-3.85,;4.67,-3.08,;4.67,-1.54,;6,-.77,;7.34,-1.54,;3.33,-.77,;3.33,.77,;4.67,1.54,;4.67,3.08,;3.33,3.85,;2,3.08,;.67,3.85,;-.67,3.08,;-.67,1.54,;-2,.77,;-3.33,1.54,;-3.33,3.08,;-4.67,3.85,;-6,3.08,;-7.34,3.85,;-8.67,3.08,;-8.67,1.54,;-7.34,.77,;-6,1.54,;-4.67,.77,;.67,.77,;2,1.54,)| Show InChI InChI=1S/C23H22N4O2/c28-19-6-8-20(9-7-19)29-21-3-1-2-17-14-25-23(27-22(17)21)26-18-5-4-16-13-24-11-10-15(16)12-18/h1-5,10-14,19-20,28H,6-9H2,(H,25,26,27)/t19-,20+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148393 (US9682961, 38) Show SMILES Cc1ccc2cc(Nc3ncc4cccc(O[C@@H]5CC[C@H](O)CC5)c4n3)ccc2n1 |r,wU:17.16,20.20,(-9.34,3.85,;-8,3.08,;-8,1.54,;-6.67,.77,;-5.33,1.54,;-4,.77,;-2.67,1.54,;-1.33,.77,;,1.54,;,3.08,;1.33,3.85,;2.67,3.08,;4,3.85,;5.33,3.08,;5.33,1.54,;4,.77,;4,-.77,;5.33,-1.54,;5.33,-3.08,;6.67,-3.85,;8,-3.08,;9.34,-3.85,;8,-1.54,;6.67,-.77,;2.67,1.54,;1.33,.77,;-2.67,3.08,;-4,3.85,;-5.33,3.08,;-6.67,3.85,)| Show InChI InChI=1S/C24H24N4O2/c1-15-5-6-16-13-18(7-12-21(16)26-15)27-24-25-14-17-3-2-4-22(23(17)28-24)30-20-10-8-19(29)9-11-20/h2-7,12-14,19-20,29H,8-11H2,1H3,(H,25,27,28)/t19-,20+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148386 (US9682961, 32) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cc(F)cc2cnc(Nc3ccc4nc[nH]c4c3)nc12 |r,wU:4.7,1.0,(8.52,-3.85,;7.19,-3.08,;5.85,-3.85,;4.52,-3.08,;4.52,-1.54,;5.85,-.77,;7.19,-1.54,;3.19,-.77,;3.19,.77,;4.52,1.54,;4.52,3.08,;5.85,3.85,;3.19,3.85,;1.85,3.08,;.52,3.85,;-.82,3.08,;-.82,1.54,;-2.15,.77,;-3.48,1.54,;-3.48,3.08,;-4.82,3.85,;-6.15,3.08,;-7.61,3.56,;-8.52,2.31,;-7.61,1.06,;-6.15,1.54,;-4.82,.77,;.52,.77,;1.85,1.54,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148389 (US9682961, 35) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccc4ncccc4c3)nc12 |r,wU:4.7,1.0,(8.67,-3.85,;7.34,-3.08,;6,-3.85,;4.67,-3.08,;4.67,-1.54,;6,-.77,;7.34,-1.54,;3.33,-.77,;3.33,.77,;4.67,1.54,;4.67,3.08,;3.33,3.85,;2,3.08,;.67,3.85,;-.67,3.08,;-.67,1.54,;-2,.77,;-3.33,1.54,;-3.33,3.08,;-4.67,3.85,;-6,3.08,;-7.34,3.85,;-8.67,3.08,;-8.67,1.54,;-7.34,.77,;-6,1.54,;-4.67,.77,;.67,.77,;2,1.54,)| Show InChI InChI=1S/C23H22N4O2/c28-18-7-9-19(10-8-18)29-21-5-1-3-16-14-25-23(27-22(16)21)26-17-6-11-20-15(13-17)4-2-12-24-20/h1-6,11-14,18-19,28H,7-10H2,(H,25,26,27)/t18-,19+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148403 (US9682961, 45) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccnc4cc(F)ccc34)nc12 |r,wU:4.7,1.0,(8.67,-3.85,;7.34,-3.08,;6,-3.85,;4.67,-3.08,;4.67,-1.54,;6,-.77,;7.34,-1.54,;3.33,-.77,;3.33,.77,;4.67,1.54,;4.67,3.08,;3.33,3.85,;2,3.08,;.67,3.85,;-.67,3.08,;-.67,1.54,;-2,.77,;-3.33,1.54,;-3.33,3.08,;-4.67,3.85,;-6,3.08,;-6,1.54,;-7.34,.77,;-7.34,-.77,;-8.67,-1.54,;-6,-1.54,;-4.67,-.77,;-4.67,.77,;.67,.77,;2,1.54,)| Show InChI InChI=1S/C23H21FN4O2/c24-15-4-9-18-19(10-11-25-20(18)12-15)27-23-26-13-14-2-1-3-21(22(14)28-23)30-17-7-5-16(29)6-8-17/h1-4,9-13,16-17,29H,5-8H2,(H,25,26,27,28)/t16-,17+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148404 (US9682961, 46) Show SMILES COc1ccc2c(Nc3ncc4cccc(O[C@@H]5CC[C@H](O)CC5)c4n3)ccnc2c1 |r,wU:17.16,20.20,(-8.67,-3.08,;-8.67,-1.54,;-7.34,-.77,;-6,-1.54,;-4.67,-.77,;-4.67,.77,;-3.33,1.54,;-2,.77,;-.67,1.54,;-.67,3.08,;.67,3.85,;2,3.08,;3.33,3.85,;4.67,3.08,;4.67,1.54,;3.33,.77,;3.33,-.77,;4.67,-1.54,;4.67,-3.08,;6,-3.85,;7.34,-3.08,;8.67,-3.85,;7.34,-1.54,;6,-.77,;2,1.54,;.67,.77,;-3.33,3.08,;-4.67,3.85,;-6,3.08,;-6,1.54,;-7.34,.77,)| Show InChI InChI=1S/C24H24N4O3/c1-30-18-9-10-19-20(11-12-25-21(19)13-18)27-24-26-14-15-3-2-4-22(23(15)28-24)31-17-7-5-16(29)6-8-17/h2-4,9-14,16-17,29H,5-8H2,1H3,(H,25,26,27,28)/t16-,17+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148368 (US9682961, 20) Show SMILES Cc1nc2c(C)cc(Nc3ncc4cccc(O[C@@H]5CC[C@H](O)CC5)c4n3)cc2[nH]1 |r,wU:18.17,21.21,(-9.33,1.54,;-7.79,1.54,;-6.84,2.79,;-5.38,2.31,;-4.05,3.08,;-4.05,4.62,;-2.71,2.31,;-2.71,.77,;-1.38,,;-.05,.77,;-.05,2.31,;1.29,3.08,;2.62,2.31,;3.96,3.08,;5.29,2.31,;5.29,.77,;3.96,,;3.96,-1.54,;5.29,-2.31,;5.29,-3.85,;6.62,-4.62,;7.96,-3.85,;9.29,-4.62,;7.96,-2.31,;6.62,-1.54,;2.62,.77,;1.29,,;-4.05,,;-5.38,.77,;-6.84,.29,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148376 (US9682961, 25) Show SMILES COCc1nc2ccc(Nc3ncc4cccc(O[C@@H]5CC[C@H](O)CC5)c4n3)cc2[nH]1 |r,wU:19.18,22.22,(-8.91,-.36,;-9.68,.98,;-8.91,2.31,;-7.37,2.31,;-6.46,3.56,;-5,3.08,;-3.66,3.85,;-2.33,3.08,;-2.33,1.54,;-.99,.77,;.34,1.54,;.34,3.08,;1.67,3.85,;3.01,3.08,;4.34,3.85,;5.67,3.08,;5.67,1.54,;4.34,.77,;4.34,-.77,;5.67,-1.54,;5.67,-3.08,;7.01,-3.85,;8.34,-3.08,;9.68,-3.85,;8.34,-1.54,;7.01,-.77,;3.01,1.54,;1.67,.77,;-3.66,.77,;-5,1.54,;-6.46,1.06,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	650	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396288 (US10314832, Compound 11 | US10314832, Compound 4) Show SMILES COCCOCOc1ccc(cc1)C(=O)CCC(=O)c1ccc2OCCOc2c1 Show InChI InChI=1S/C22H24O7/c1-25-10-11-26-15-29-18-5-2-16(3-6-18)19(23)7-8-20(24)17-4-9-21-22(14-17)28-13-12-27-21/h2-6,9,14H,7-8,10-13,15H2,1H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	805	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396289 (US10314832, Compound 5) Show SMILES O=C(CCC(=O)c1ccccn1)c1cccs1 Show InChI InChI=1S/C13H11NO2S/c15-11(10-4-1-2-8-14-10)6-7-12(16)13-5-3-9-17-13/h1-5,8-9H,6-7H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.27E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396298 (US10314832, Compound 15) Show SMILES O=C(CC(=O)c1ccccn1)c1ccc2OCCOc2c1 Show InChI InChI=1S/C16H13NO4/c18-13(10-14(19)12-3-1-2-6-17-12)11-4-5-15-16(9-11)21-8-7-20-15/h1-6,9H,7-8,10H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.39E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50509812 (CHEMBL4548532) Show SMILES OC(=O)CC[C@H](NC(=O)[C@H](Cc1nn[nH]n1)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)c1cc2c(Cl)cc(Cl)cc2[nH]1)C(=O)Nc1ccc(OC(F)(F)F)cc1 |r| Show InChI InChI=1S/C38H32Cl2F3N9O7/c39-22-15-26(40)25-17-30(45-28(25)16-22)36(57)47-29(14-19-5-6-20-3-1-2-4-21(20)13-19)35(56)48-31(18-32-49-51-52-50-32)37(58)46-27(11-12-33(53)54)34(55)44-23-7-9-24(10-8-23)59-38(41,42)43/h1-10,13,15-17,27,29,31,45H,11-12,14,18H2,(H,44,55)(H,46,58)(H,47,57)(H,48,56)(H,53,54)(H,49,50,51,52)/t27-,29-,31-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.70E+3	n/a	n/a	n/a	n/a	n/a	n/a
H. Lee Moffitt Cancer Center and Research Institute Curated by ChEMBL					Assay Description Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...				J Med Chem 62: 3617-3635 (2019) Article DOI: 10.1021/acs.jmedchem.9b00147 BindingDB Entry DOI: 10.7270/Q2KP85G5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148366 (US9682961, 19) Show SMILES Cc1nc2c(Br)cc(Nc3ncc4cccc(O[C@@H]5CC[C@H](O)CC5)c4n3)cc2[nH]1 |r,wU:18.17,21.21,(-9.29,1.54,;-7.75,1.54,;-6.84,2.79,;-5.38,2.31,;-4.05,3.08,;-4.05,4.62,;-2.71,2.31,;-2.71,.77,;-1.38,,;-.05,.77,;-.05,2.31,;1.29,3.08,;2.62,2.31,;3.96,3.08,;5.29,2.31,;5.29,.77,;3.96,,;3.96,-1.54,;5.29,-2.31,;5.29,-3.85,;6.62,-4.62,;7.96,-3.85,;9.29,-4.62,;7.96,-2.31,;6.62,-1.54,;2.62,.77,;1.29,,;-4.05,,;-5.38,.77,;-6.84,.29,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148397 (US9682961, 40) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccc4ccncc4c3)nc12 |r,wU:4.7,1.0,(8.67,-3.85,;7.34,-3.08,;6,-3.85,;4.67,-3.08,;4.67,-1.54,;6,-.77,;7.34,-1.54,;3.33,-.77,;3.33,.77,;4.67,1.54,;4.67,3.08,;3.33,3.85,;2,3.08,;.67,3.85,;-.67,3.08,;-.67,1.54,;-2,.77,;-3.33,1.54,;-3.33,3.08,;-4.67,3.85,;-6,3.08,;-7.34,3.85,;-8.67,3.08,;-8.67,1.54,;-7.34,.77,;-6,1.54,;-4.67,.77,;.67,.77,;2,1.54,)| Show InChI InChI=1S/C23H22N4O2/c28-19-6-8-20(9-7-19)29-21-3-1-2-16-14-25-23(27-22(16)21)26-18-5-4-15-10-11-24-13-17(15)12-18/h1-5,10-14,19-20,28H,6-9H2,(H,25,26,27)/t19-,20+	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50589223 (CHEMBL5185515) Show SMILES NS(=O)(=O)c1ccc(NC(=S)N2CCN(C\C=C\c3ccccc3)CC2)cc1 Show InChI	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	Article PubMed	n/a	n/a	2.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details Article DOI: 10.1021/acs.jmedchem.2c00228 BindingDB Entry DOI: 10.7270/Q2GQ72Q3
					More data for this Ligand-Target Pair
Catenin beta-1/Protein Wnt-3a (Homo sapiens (Human))	BDBM148377 (US9682961, 26) Show SMILES O[C@H]1CC[C@H](CC1)Oc1cccc2cnc(Nc3ccc4nc([nH]c4c3)C(F)(F)F)nc12 |r,wU:4.7,1.0,(9.29,-3.85,;7.96,-3.08,;6.62,-3.85,;5.29,-3.08,;5.29,-1.54,;6.62,-.77,;7.96,-1.54,;3.96,-.77,;3.96,.77,;5.29,1.54,;5.29,3.08,;3.96,3.85,;2.62,3.08,;1.29,3.85,;-.05,3.08,;-.05,1.54,;-1.38,.77,;-2.71,1.54,;-2.71,3.08,;-4.05,3.85,;-5.38,3.08,;-6.84,3.56,;-7.75,2.31,;-6.84,1.06,;-5.38,1.54,;-4.05,.77,;-9.29,2.31,;-10.06,3.64,;-10.06,.98,;-8.52,.98,;1.29,.77,;2.62,1.54,)| Show InChI	PDB UniProtKB/SwissProt antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
CARNA BIOSCIENCES, INC.; NATIONAL CANCER CENTER US Patent					Assay Description Using ONE-Glo Luciferase Assay System (Promega Corporation, No. E6110), the luciferase activity of the cells in the wells was measured by a microplat...				US Patent US9682961 (2017) BindingDB Entry DOI: 10.7270/Q2K935P5
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396290 (US10314832, Compound 6) Show SMILES Oc1cccc(c1)C(=O)CCC(=O)c1ccc2OCCOc2c1 Show InChI InChI=1S/C18H16O5/c19-14-3-1-2-12(10-14)15(20)5-6-16(21)13-4-7-17-18(11-13)23-9-8-22-17/h1-4,7,10-11,19H,5-6,8-9H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.10E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50509813 (CHEMBL4451478) Show SMILES OC(=O)CC[C@H](NC(=O)[C@H](Cc1nn[nH]n1)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)c1cc2cc(Cl)ccc2[nH]1)C(=O)Nc1ccc(OC(F)(F)F)cc1 |r| Show InChI InChI=1S/C38H33ClF3N9O7/c39-24-7-12-27-23(17-24)18-30(44-27)36(56)46-29(16-20-5-6-21-3-1-2-4-22(21)15-20)35(55)47-31(19-32-48-50-51-49-32)37(57)45-28(13-14-33(52)53)34(54)43-25-8-10-26(11-9-25)58-38(40,41)42/h1-12,15,17-18,28-29,31,44H,13-14,16,19H2,(H,43,54)(H,45,57)(H,46,56)(H,47,55)(H,52,53)(H,48,49,50,51)/t28-,29-,31-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	2.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
H. Lee Moffitt Cancer Center and Research Institute Curated by ChEMBL					Assay Description Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...				J Med Chem 62: 3617-3635 (2019) Article DOI: 10.1021/acs.jmedchem.9b00147 BindingDB Entry DOI: 10.7270/Q2KP85G5
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396299 (US10314832, Compound 16) Show SMILES O=C(CC(=O)c1ccc2OCCOc2c1)c1cccs1 Show InChI InChI=1S/C15H12O4S/c16-11(9-12(17)15-2-1-7-20-15)10-3-4-13-14(8-10)19-6-5-18-13/h1-4,7-8H,5-6,9H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	2.57E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396302 (US10314832, Compound 19) Show SMILES O=C(C(Cc1cccc2ccccc12)C(=O)c1ccccc1)c1ccccc1 Show InChI InChI=1S/C26H20O2/c27-25(20-11-3-1-4-12-20)24(26(28)21-13-5-2-6-14-21)18-22-16-9-15-19-10-7-8-17-23(19)22/h1-17,24H,18H2	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	3.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50436055 (CHEMBL2397076) Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@](C)(CCC\C=C/CCC[C@](C)(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O |r,wU:8.8,18.18,2.2,31.31,23.23,42.42,59.60,81.82,102.105,116.125,132.149,146.160,157.171,wD:4.3,18.39,52.53,70.71,88.89,8.116,125.128,c:13,(20.12,-51.04,;18.77,-50.3,;18.73,-48.76,;20.04,-47.96,;17.37,-48.03,;16.05,-48.83,;14.7,-48.11,;14.65,-46.57,;13.36,-48.91,;12.59,-50.22,;14.13,-50.23,;13.35,-51.56,;14.12,-52.89,;25.82,-50.54,;26.59,-49.21,;25.83,-47.88,;26.6,-46.55,;25.84,-45.22,;26.6,-43.9,;27.36,-45.22,;25.24,-43.18,;23.93,-43.98,;23.96,-45.52,;22.55,-43.25,;22.51,-41.71,;23.83,-40.89,;25.2,-41.63,;23.79,-39.35,;21.26,-44.05,;19.9,-43.33,;19.86,-41.79,;18.59,-44.13,;17.25,-43.4,;17.2,-41.86,;15.82,-41.13,;18.5,-41.05,;18.64,-45.67,;17.33,-46.49,;15.96,-45.75,;27.92,-43.1,;27.88,-41.56,;29.28,-43.82,;30.59,-43.02,;30.55,-41.48,;31.86,-40.66,;31.98,-39.12,;33.47,-38.76,;34.28,-40.08,;33.28,-41.25,;31.94,-43.75,;32,-45.29,;33.25,-42.94,;34.61,-43.67,;34.65,-45.21,;33.34,-46.02,;36.02,-45.95,;35.92,-42.86,;35.87,-41.32,;37.28,-43.59,;38.59,-42.78,;38.54,-41.24,;39.88,-40.43,;39.83,-38.89,;41.13,-38.08,;41.1,-36.54,;39.74,-35.81,;42.4,-35.73,;39.96,-43.51,;40.01,-45.05,;41.28,-42.7,;42.62,-43.43,;42.67,-44.98,;44.03,-45.71,;44.07,-47.25,;45.43,-47.99,;45.48,-49.53,;46.84,-50.26,;44.16,-50.34,;43.94,-42.62,;43.9,-41.08,;45.3,-43.36,;46.61,-42.55,;46.57,-41,;45.21,-40.27,;47.89,-40.2,;47.97,-43.28,;48.02,-44.82,;49.29,-42.47,;50.65,-43.2,;50.69,-44.75,;52.05,-45.48,;53.43,-44.81,;54.5,-45.93,;53.77,-47.28,;54.28,-48.74,;53.28,-49.92,;51.77,-49.63,;51.25,-48.18,;52.26,-47,;51.96,-42.4,;51.91,-40.85,;53.3,-43.13,;54.62,-42.32,;54.58,-40.78,;55.89,-39.97,;55.85,-38.42,;57.16,-37.61,;58.52,-38.35,;59.84,-37.54,;58.57,-39.89,;55.98,-43.05,;57.29,-42.24,;56.03,-44.59,;12.02,-48.16,;10.71,-48.95,;10.73,-50.48,;9.37,-48.19,;9.35,-46.66,;10.66,-45.87,;10.64,-44.34,;9.3,-43.59,;11.96,-43.56,;8.05,-48.98,;6.71,-48.23,;6.69,-46.7,;5.38,-49.01,;5.25,-50.55,;3.76,-50.89,;2.97,-49.57,;3.98,-48.41,;3.64,-46.92,;4.77,-45.87,;2.18,-46.46,;1.83,-44.97,;2.96,-43.92,;4.45,-44.22,;5.2,-42.89,;4.17,-41.77,;4.31,-40.23,;3.05,-39.35,;1.65,-40,;1.52,-41.52,;2.77,-42.4,;1.04,-47.51,;-.42,-47.05,;-.77,-45.56,;-1.55,-48.1,;-3.02,-47.64,;-3.36,-46.15,;-4.83,-45.69,;-5.18,-44.19,;-6.64,-43.74,;-6.98,-42.24,;-7.76,-44.79,;-1.21,-49.59,;-2.35,-50.63,;-3.81,-50.18,;-2.01,-52.13,;-3.12,-53.17,;-4.59,-52.72,;-5.71,-53.77,;-7.19,-53.31,;-8.31,-54.36,;-9.78,-53.9,;-7.97,-55.85,;-.54,-52.58,;-.2,-54.08,;1.28,-54.54,;-1.32,-55.13,)| Show InChI InChI=1S/C110H174N38O21/c1-12-61(8)86-100(166)139-76(49-58(2)3)92(158)138-79(53-83(151)152)96(162)147-109(10,41-21-15-13-14-16-22-42-110(11,103(169)145-86)146-95(161)75(39-40-82(111)150)136-97(163)81-38-28-48-148(81)101(167)80(51-64-55-130-69-32-20-18-30-67(64)69)141-90(156)72(35-25-45-126-106(117)118)134-88(154)71(132-62(9)149)34-24-44-125-105(115)116)102(168)142-78(52-65-56-123-57-131-65)94(160)144-84(59(4)5)98(164)137-73(36-26-46-127-107(119)120)89(155)135-74(37-27-47-128-108(121)122)91(157)143-85(60(6)7)99(165)140-77(50-63-54-129-68-31-19-17-29-66(63)68)93(159)133-70(87(112)153)33-23-43-124-104(113)114/h13-14,17-20,29-32,54-61,70-81,84-86,129-130H,12,15-16,21-28,33-53H2,1-11H3,(H2,111,150)(H2,112,153)(H,123,131)(H,132,149)(H,133,159)(H,134,154)(H,135,155)(H,136,163)(H,137,164)(H,138,158)(H,139,166)(H,140,165)(H,141,156)(H,142,168)(H,143,157)(H,144,160)(H,145,169)(H,146,161)(H,147,162)(H,151,152)(H4,113,114,124)(H4,115,116,125)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)/b14-13-/t61-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,84-,85-,86-,109-,110-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Chemical Genomics Centre of the Max Planck Society Curated by ChEMBL					Assay Description Inhibition of beta-catenin-mediated transcriptional activity in Wnt3a-stimulated human HeLa cells after 24 hrs by Dual-Glo luciferase reporter gene a...				Bioorg Med Chem 21: 4020-6 (2013) Article DOI: 10.1016/j.bmc.2013.02.050 BindingDB Entry DOI: 10.7270/Q2BP046Z
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50436054 (CHEMBL2397077) Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@](C)(CCC\C=C/CCC[C@](C)(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC1=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(C)=O |r,wU:8.8,18.18,2.2,31.31,23.23,42.42,59.60,81.82,102.105,116.127,134.151,148.162,159.173,wD:4.3,18.39,52.53,70.71,88.89,8.116,127.130,c:13,(25.34,-10.98,;23.99,-10.24,;23.95,-8.7,;25.26,-7.9,;22.59,-7.97,;21.26,-8.77,;19.92,-8.05,;19.87,-6.51,;18.58,-8.85,;17.81,-10.16,;19.34,-10.17,;18.57,-11.5,;19.33,-12.83,;31.04,-10.48,;31.81,-9.15,;31.04,-7.82,;31.82,-6.49,;31.05,-5.16,;31.82,-3.84,;32.58,-5.16,;30.46,-3.12,;29.14,-3.92,;29.18,-5.46,;27.77,-3.19,;27.73,-1.65,;29.05,-.83,;30.42,-1.57,;29.01,.71,;26.48,-3.99,;25.11,-3.27,;25.08,-1.73,;23.81,-4.07,;22.47,-3.34,;22.42,-1.8,;21.04,-1.07,;23.72,-.98,;23.86,-5.61,;22.55,-6.43,;21.18,-5.69,;33.14,-3.04,;33.09,-1.5,;34.5,-3.76,;35.81,-2.96,;35.76,-1.42,;37.08,-.6,;37.2,.95,;38.69,1.3,;39.49,-.02,;38.5,-1.19,;37.16,-3.69,;37.22,-5.23,;38.47,-2.88,;39.83,-3.61,;39.87,-5.15,;38.56,-5.96,;41.24,-5.89,;41.14,-2.8,;41.09,-1.26,;42.49,-3.53,;43.81,-2.72,;43.76,-1.18,;45.09,-.37,;45.05,1.18,;46.35,2,;46.31,3.54,;44.96,4.26,;47.62,4.34,;45.18,-3.45,;45.23,-4.99,;46.5,-2.64,;47.84,-3.37,;47.89,-4.92,;49.25,-5.65,;49.29,-7.19,;50.65,-7.93,;50.7,-9.47,;52.06,-10.2,;49.38,-10.28,;49.15,-2.56,;49.12,-1.02,;50.52,-3.3,;51.83,-2.49,;51.79,-.94,;50.43,-.21,;53.11,-.14,;53.19,-3.22,;53.24,-4.76,;54.51,-2.41,;55.87,-3.14,;55.91,-4.69,;57.27,-5.42,;58.65,-4.74,;59.71,-5.87,;58.99,-7.22,;59.5,-8.68,;58.5,-9.85,;56.98,-9.57,;56.47,-8.12,;57.48,-6.94,;57.18,-2.34,;57.13,-.79,;58.52,-3.07,;59.84,-2.26,;59.8,-.72,;61.11,.1,;61.07,1.65,;62.38,2.45,;63.74,1.72,;65.06,2.53,;63.79,.18,;61.2,-2.99,;62.51,-2.18,;61.25,-4.53,;17.24,-8.1,;15.92,-8.88,;15.95,-10.42,;14.59,-8.13,;14.57,-6.6,;15.88,-5.81,;15.86,-4.28,;17.23,-3.46,;17.21,-1.86,;18.58,-1.05,;15.81,-1.09,;13.26,-8.92,;11.93,-8.17,;11.9,-6.64,;10.6,-8.95,;10.47,-10.49,;8.97,-10.83,;8.19,-9.51,;9.2,-8.35,;8.86,-6.86,;9.99,-5.81,;7.39,-6.4,;7.05,-4.91,;8.18,-3.86,;9.67,-4.16,;10.42,-2.83,;9.39,-1.71,;9.53,-.17,;8.27,.72,;6.87,.07,;6.74,-1.46,;7.99,-2.34,;6.26,-7.45,;4.8,-6.99,;4.46,-5.5,;3.67,-8.04,;2.21,-7.58,;1.86,-6.09,;.4,-5.63,;.06,-4.13,;-1.42,-3.68,;-1.77,-2.18,;-2.55,-4.73,;4.01,-9.53,;2.89,-10.57,;1.42,-10.12,;3.22,-12.07,;2.1,-13.11,;.63,-12.66,;-.49,-13.71,;-1.97,-13.25,;-3.09,-14.3,;-4.56,-13.84,;-2.75,-15.79,;4.69,-12.52,;5.03,-14.02,;6.5,-14.48,;3.91,-15.07,)| Show InChI InChI=1S/C111H178N40O20/c1-12-62(8)86-100(168)142-77(50-59(2)3)92(160)141-80(54-83(153)154)96(164)150-110(10,41-21-15-13-14-16-22-42-111(11,103(171)148-86)149-95(163)76(39-28-48-131-109(123)124)139-97(165)82-40-29-49-151(82)101(169)81(52-65-56-133-70-33-20-18-31-68(65)70)144-90(158)73(36-25-45-128-106(117)118)137-88(156)72(135-63(9)152)35-24-44-127-105(115)116)102(170)145-79(53-66-57-125-58-134-66)94(162)147-84(60(4)5)98(166)140-74(37-26-46-129-107(119)120)89(157)138-75(38-27-47-130-108(121)122)91(159)146-85(61(6)7)99(167)143-78(51-64-55-132-69-32-19-17-30-67(64)69)93(161)136-71(87(112)155)34-23-43-126-104(113)114/h13-14,17-20,30-33,55-62,71-82,84-86,132-133H,12,15-16,21-29,34-54H2,1-11H3,(H2,112,155)(H,125,134)(H,135,152)(H,136,161)(H,137,156)(H,138,157)(H,139,165)(H,140,166)(H,141,160)(H,142,168)(H,143,167)(H,144,158)(H,145,170)(H,146,159)(H,147,162)(H,148,171)(H,149,163)(H,150,164)(H,153,154)(H4,113,114,126)(H4,115,116,127)(H4,117,118,128)(H4,119,120,129)(H4,121,122,130)(H4,123,124,131)/b14-13-/t62-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,84-,85-,86-,110-,111-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Chemical Genomics Centre of the Max Planck Society Curated by ChEMBL					Assay Description Inhibition of beta-catenin-mediated transcriptional activity in Wnt3a-stimulated human HeLa cells after 24 hrs by Dual-Glo luciferase reporter gene a...				Bioorg Med Chem 21: 4020-6 (2013) Article DOI: 10.1016/j.bmc.2013.02.050 BindingDB Entry DOI: 10.7270/Q2BP046Z
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50509810 (CHEMBL4464142) Show SMILES OC(=O)C[C@H](NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)c1cc2cc(Cl)ccc2[nH]1)C(=O)N[C@@H](Cc1nn[nH]n1)C(=O)Nc1ccc(OC(F)(F)F)cc1 |r| Show InChI InChI=1S/C37H31ClF3N9O7/c38-23-7-12-26-22(15-23)16-28(43-26)35(55)44-27(14-19-5-6-20-3-1-2-4-21(20)13-19)34(54)46-30(18-32(51)52)36(56)45-29(17-31-47-49-50-48-31)33(53)42-24-8-10-25(11-9-24)57-37(39,40)41/h1-13,15-16,27,29-30,43H,14,17-18H2,(H,42,53)(H,44,55)(H,45,56)(H,46,54)(H,51,52)(H,47,48,49,50)/t27-,29-,30-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	5.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
H. Lee Moffitt Cancer Center and Research Institute Curated by ChEMBL					Assay Description Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...				J Med Chem 62: 3617-3635 (2019) Article DOI: 10.1021/acs.jmedchem.9b00147 BindingDB Entry DOI: 10.7270/Q2KP85G5
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM396301 (US10314832, Compound 18) Show SMILES CCC(CC)(C(=O)c1ccccc1)C(=O)c1ccc2OCCOc2c1 Show InChI InChI=1S/C21H22O4/c1-3-21(4-2,19(22)15-8-6-5-7-9-15)20(23)16-10-11-17-18(14-16)25-13-12-24-17/h5-11,14H,3-4,12-13H2,1-2H3	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	6.00E+3	n/a	n/a	n/a	n/a	n/a	n/a
Novartis					Assay Description Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...				J Med Chem 52: 3523-38 (2009) BindingDB Entry DOI: 10.7270/Q2M047TC
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50014148 (CHEMBL3260853) Show SMILES COC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)Cc1cc2cc(Cl)ccc2[nH]1 |r| Show InChI InChI=1S/C33H33ClN4O9/c1-47-33(46)25(10-11-29(40)41)37-32(45)27(17-30(42)43)38-31(44)26(13-18-6-7-19-4-2-3-5-20(19)12-18)36-28(39)16-23-15-21-14-22(34)8-9-24(21)35-23/h2-9,12,14-15,25-27,35H,10-11,13,16-17H2,1H3,(H,36,39)(H,37,45)(H,38,44)(H,40,41)(H,42,43)/t25-,26-,27-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase CHEMBL MCE PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.30E+3	n/a	n/a	n/a	n/a	n/a	n/a
University of Utah Curated by ChEMBL					Assay Description Inhibition of human wild-type beta-catenin (residues 138-686)/C-terminally fluorescein labeled human wild-type Tcf4 (residues 7-51) interaction after...				J Med Chem 58: 4678-92 (2015) Article DOI: 10.1021/acs.jmedchem.5b00223 BindingDB Entry DOI: 10.7270/Q2G44S28
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50509801 (CHEMBL4464433) Show SMILES OC(=O)CC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)c1cc2cc(Cl)ccc2[nH]1)C(=O)Nc1ccc(cc1)C(F)(F)F |r| Show InChI InChI=1S/C38H33ClF3N5O8/c39-25-9-12-27-23(17-25)18-30(44-27)36(54)46-29(16-20-5-6-21-3-1-2-4-22(21)15-20)35(53)47-31(19-33(50)51)37(55)45-28(13-14-32(48)49)34(52)43-26-10-7-24(8-11-26)38(40,41)42/h1-12,15,17-18,28-29,31,44H,13-14,16,19H2,(H,43,52)(H,45,55)(H,46,54)(H,47,53)(H,48,49)(H,50,51)/t28-,29-,31-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	Article PubMed	n/a	n/a	7.30E+3	n/a	n/a	n/a	n/a	n/a	n/a
H. Lee Moffitt Cancer Center and Research Institute Curated by ChEMBL					Assay Description Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...				J Med Chem 62: 3617-3635 (2019) Article DOI: 10.1021/acs.jmedchem.9b00147 BindingDB Entry DOI: 10.7270/Q2KP85G5
					More data for this Ligand-Target Pair
Catenin beta-1 (Homo sapiens (Human))	BDBM50509781 (CHEMBL4450852) Show SMILES OC(=O)CC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc2ccccc2c1)NC(=O)c1cc2cc(Cl)ccc2[nH]1)C(=O)Nc1ccc(OC(F)(F)F)cc1 |r| Show InChI InChI=1S/C38H33ClF3N5O9/c39-24-7-12-27-23(17-24)18-30(44-27)36(54)46-29(16-20-5-6-21-3-1-2-4-22(21)15-20)35(53)47-31(19-33(50)51)37(55)45-28(13-14-32(48)49)34(52)43-25-8-10-26(11-9-25)56-38(40,41)42/h1-12,15,17-18,28-29,31,44H,13-14,16,19H2,(H,43,52)(H,45,55)(H,46,54)(H,47,53)(H,48,49)(H,50,51)/t28-,29-,31-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	Purchase MCE PC cid PC sid UniChem	Article PubMed	n/a	n/a	7.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
H. Lee Moffitt Cancer Center and Research Institute Curated by ChEMBL					Assay Description Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...				J Med Chem 62: 3617-3635 (2019) Article DOI: 10.1021/acs.jmedchem.9b00147 BindingDB Entry DOI: 10.7270/Q2KP85G5
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 147 total )  |  Next  |  Last  >>

Jump to: